Beam stock forecast.

Beam Therapeutics last released its earnings results on November 8th, 2023. The reported ($1.22) earnings per share for the quarter, beating analysts' consensus estimates of ($1.33) by $0.11. The firm had revenue of $17.20 million for the quarter, compared to analyst estimates of $17.09 million. Its revenue was up 8.9% on a year-over-year basis.Feb 1, 2023 · (See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ... Find the latest Quantum-Si incorporated (QSI) stock quote, history, news and other vital information to help you with your stock trading and investing.BEST Inc. (NYSE:BEST) announced its earnings results on Monday, August, 16th. The company reported ($22.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($14.60) by $7.60. The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.26 billion.January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...

Find the latest Ion Beam Applications SA (IBAB.BR) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 17, 2023 · The mean of analysts' price targets for Beam Therapeutics Inc. (BEAM) points to an 81.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...

Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.Mar 5, 2023 · Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ... View the latest Verizon Communications Inc. (VZ) stock price, news, historical charts, analyst ratings and financial information from WSJ.Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years.

Beam Therapeutics Let’s start off in the high-risk, high-reward biotech sector. ... (See IHRT stock forecast on TipRanks) To find good ideas for stocks trading at attractive valuations, visit ...

View the real-time BEAM price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, ...The current average BEAM price target, as estimated by these analysts, is $63.00. The predictions for the future BEAM stock price range from a low of $62.00 to a high of $66.00, highlighting the variability of market expectations for BEAM. View the latest Verizon Communications Inc. (VZ) stock price, news, historical charts, analyst ratings and financial information from WSJ.Feb 1, 2023 · (See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ... BEAM stock, the ticker symbol for Beam Therapeutics Inc, experienced a significant increase in its price on October 19, 2023. According to data from CNN Money, 14 analysts have provided 12-month price forecasts for the stock. The median target price is $61.00, with a high estimate of $105.00 and a low estimate of $27.00.BEAM Stock 12 Months Forecast. $43.44. (46.41% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Beam Therapeutics in the last 3 months. The …

Find real-time DDOG - Datadog Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $0.32: Annual revenue (last year) $1.7B: Annual profit (last ...Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.Fiscal Q3 2023 ended 9/30/23. Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading... See the latest Beam Therapeutics Inc stock price (BEAM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.The Biden administration is pushing hard to promote electric vehicles (EVs). From a $7.5 billion pro

A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

AADI Stock 12 Months Forecast. $33.00. (599.15% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Aadi Bioscience in the last 3 months. The average price target is $33.00 with a high forecast of $36.00 and a low forecast of $30.00. The average price target represents a 599.15% change from the last price of $4.72.TTOO. T2 Biosystems, Inc. Common Stock. $0.56 +0.1067 +23.54%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market ... January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...Price target. 49.67 0.00 0.00%. The 12 analysts offering 1 year price forecasts for BEAM have a max estimate of — and a min estimate of —. According to our current BEAM stock forecast, the value of Beam Therapeutics shares will drop by -2.93% and reach $ 28.70 per share by December 8, …The Biden administration is pushing hard to promote electric vehicles (EVs). From a $7.5 billion provision in the ‘Build Back Better’ bill to political pressure on automakers to commit to ...October 30, 2023 at 7:00 AM · 5 min read. Wall Street expects a year-over-year increase in earnings on lower revenues when Beam Therapeutics Inc. (BEAM) reports results for the quarter ended ...

Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing ... Nov 29, 2023 · The Fly Beam Therapeutics price target lowered to $26 from $35 at Barclays. 21d ago. Press Releases Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results. 22d ago. Press Releases Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. 22d ago. Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Find the latest Beam Global (BEEM) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 2.00, with a high estimate of 8.00 and a low estimate of 0.50. The ...Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per …Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...Find real-time MELI - MercadoLibre Inc stock quotes, company profile, news and forecasts from CNN Business.

The average stock forecast for Beam Therapeutics Inc (BEAM) is 54.77 USD. This price target corresponds to an upside of 85.21%. The range of stock …(See BEAM stock forecast on TipRanks) iHeartMedia (IHRT) Let’s switch stations now and tune into something entirely different. iHeartMedia is one of the U.S.’s most prominent audio companies ...Hold candidate since Nov 13, 2023 Gain 20.46% PDF. The Beam Global stock price gained 20.46% on the last trading day (Tuesday, 14th Nov 2023), rising from $6.06 to $7.30. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comInstagram:https://instagram. shorted stocks listtrading microjp morgan privateearnings google EXAS Stock 12 Months Forecast. $95.46. (50.43% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Exact Sciences in the last 3 months. The average price target is $95.46 with a high forecast of $120.00 and a low forecast of $80.00. The average price target represents a 50.43% change from the last price of $63.46. forexrobotxyld stock dividend Ouster (NYSE: OUST) While its ticker symbol sounds ominous, Ouster LiDAR stocks could have a bright future ahead, especially within the next few years. This San Francisco-based company produces …Beam Therapeutics is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. ... We provide commentary based on historical data and analyst forecasts ... investors in spacex The Beam Therapeutics stock forecast is 57.069107374265 USD for 2024 November 25, Monday; and 177.367 USD for 2028 November 25, Saturday with technical analysis. Beam Therapeutics (BEAM) stock price prediction is 57.069107374265 USD.According to 4 Wall Street analyst s that have issued a 1 year BEAM price target, the average BEAM price target is $42.50, with the highest BEAM stock price forecast at …BEEM Stock 12 Months Forecast. $24.00. (228.09% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Beam Global in the last 3 months. The average price target is $24.00 with a high forecast of $40.00 and a low forecast of $12.00. The average price target represents a 228.09% change from the last price of $7.32.